Development and validation of a genomic mutation signature to predict response to PD-1 inhibitors in non-squamous NSCLC: a multicohort studyXue Bai, Zhong‐Yi Dong, Shuai Kang et al.|Journal for ImmunoTherapy of Cancer|2020Cited by 63